Pharmaceutical Executive: How will pharma companies react to the administration's efforts?Dr. William Soliman: We’ve seen Pfizer doing a deal with...
Drug
Key TakeawaysPharma stocks seesawed on the news of President Trump’s ultimatum to lower prices, continuing a tough year for healthcare...
The market has rallied behind the US drug distribution industry recently because of the popularity of GLP-1s, easing generic drug...
